Jeffrey S. Berger, MD, MS, FAHA, FACC
Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Wednesday, November 15, 2017 |
Friday, November 17, 2017 |
Presenter
Why ACE Inhibitors And Angiotension Receptor Blockers Should Be Stopped 24 Hours Before Vascular Surgery And What Is Optimal Antiplatelet Drug Therapy In Vascular Patients: Based On The EUCLID Trial
2:07 PM - 2:12 PM
|
Presenter
New Developments In Troponin Testing: What Is Its Value As A Risk Predictor In Patients Undergoing Endo And Open Vascular Procedures: Value Of New High Sensitivity Troponin Assay
2:19 PM - 2:24 PM
|
Presenter
Which Patients Should Receive Primary Prevention Lipid Lowering Statin Therapy: What Drug And Dose: How Do The HOPE 3 Trial Findings Help
2:25 PM - 2:30 PM
|
previous | next |